NCT07082933View on ClinicalTrials.gov

Long-term Survival and Influencing Factors of Patients With Pulmonary Arterial Hypertension and Diabetes

Not yet recruitingOBSERVATIONAL

Enrollment

5,000

Participants

Timeline

Start Date

August 1, 2025

Primary Completion Date

August 1, 2027

Study Completion Date

December 31, 2027

Conditions

Pulmonary Arterial Hypertension (PAH)

Interventions

OTHER

Standard medical treatment

Standard medical treatment

All Listed Sponsors

lead

Xijing Hospital

OTHER